Study
Integrative Oncogenomics of multiple myeloma
Study ID | Alternative Stable ID | Type |
---|---|---|
EGAS00001000243 | Other |
Study Description
We used targeted capture and massively parallel sequencing of exomes of CD138 purified plasma cells and matched somatic DNA from 53 patients with Multiple Myeloma. 2281 variants were validated by 454 sequencing. The present study will validate an additional 5538 variants by targeted pull-down and sequencing. The normal and tumor samples will be indexed separately and pre-pooled in groups of 10 or 11. The sequence capture will use 5 reactions each for the normals and tumors. All normal samples will then be pooled and go thorugh one lane of HiSeq. Same for the tumors.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001000246 |
Integrative Oncogenomics of multiple myeloma
|
Illumina HiSeq 2000 | 106 |
Who archives the data?
